(Q50791517)

English

Tailoring clopidogrel dose according to multiple electrode aggregometry decreases the rate of ischemic complications after percutaneous coronary intervention.

scientific article published in July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

Tailoring clopidogrel dose according to multiple electrode aggregometry decreases the rate of ischemic complications after percutaneous coronary intervention. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

1 reference

based on heuristic

inferred from title

author name string

Dobri Hazarbasanov

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

Vasil Velchev

2

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

Bozhidar Finkov

3

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

Arman Postadjian

4

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

Emil Kostov

5

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

Nizar Rifai

6

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

Dániel Aradi

7

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

publication date

1 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

34

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

85-90

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

https://scigraph.springernature.com/pub.10.1007/s11239-012-0684-z

0 references

Variability in platelet responsiveness to clopidogrel among 544 individuals.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

Modifying clopidogrel maintenance doses according to vasodilator-stimulated phosphoprotein phosphorylation index improves clinical outcome in patients with clopidogrel resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

Guidelines on myocardial revascularization

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial dama

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0684-Z

21 January 2018

Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22249353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The EFFect of hIgh-dose ClopIdogrel treatmENT in patients with clopidogrel resistance (the EFFICIENT trial)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22249353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11239-012-0684-Z

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/22249353

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50791517&oldid=1412006133"